TAP Block With Two Different Doses of Levobupivacaine

Comparison of TAP Block With Two Different Doses of Levobupivacaine for Postoperative Pain Management in Pediatric Patients

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02567487

Enrollment

Registered

2015-10-05

Start date

2015-07-31

Completion date

2016-07-31

Last updated

2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery. The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.

Detailed description

Fifty children undergoing TAP block were randomly divided into two groups as levobupivacaine 0.25% 0.5 ml/kg and levobupivacaine 0.25% 0.25 ml/kg. Postoperative pain was evaluated with observational pain scale and modified pediatric objective pain scale.

Interventions

DRUGLevobupivacaine

Transversus abdominis plane block with levobupivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

2 Years to 12 Years

Healthy volunteers

Inclusion criteria

* Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and iliohypogastric block) and general anesthesia * Aged between 2 and 12

Exclusion criteria

* Patients with coagulation dysfunction * Patients with chronic pain * Patients having infection at the site of intervention * Patients with a history of allergy * Patients having chronic diseases (hepatic dysfunction, renal failure)

Design outcomes

Primary

Measure	Time frame
postoperative VAS score <4 at postoperative 24 hours	Postoperative first 24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026